Filing Flows › Viemed Healthcare (VMD) › Stock forecast & fair value
Viemed Healthcare (VMD) stock forecast and price target
Viemed Healthcare (VMD) trades at $9.13. 2 analysts' median price target is $12.50 (+37%), from $11.00 to $14.00.
Viemed Healthcare's latest quarter
Viemed Healthcare, Q3 2026: revenue $80.7M (+12% year over year), operating margin 8.6%, net earnings $4.6M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for VMD stock?
The median of 2 analysts' 12-month targets is $12.50, +37% from $9.13; the range is $11.00 to $14.00. The average rating is buy.
Does Viemed Healthcare usually beat earnings estimates?
It beat the consensus EPS estimate in 20% of the quarters on record.
Is VMD stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.